Literature DB >> 15843707

Best evidence topic report. Buccal midazolam as an alternative to rectal diazepam for prolonged seizures in childhood and adolescence.

Richard Body, Mawra Ijaz.   

Abstract

A short cut review was carried out to establish whether buccal midazolam is better than rectal diazepam for treating prolonged seizures in childhood and adolescence. Eight papers were found using the reported search, of which two presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of these best papers are tabulated. A clinical bottom line is stated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843707      PMCID: PMC1726775          DOI: 10.1136/emj.2005.024380

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  3 in total

Review 1.  Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures.

Authors:  Karly P Garnock-Jones
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

Review 2.  Generalised convulsive status epilepticus: an overview.

Authors:  R Nandhagopal
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

3.  Oromucosal midazolam: a guide to its use in paediatric patients with prolonged acute convulsive seizures.

Authors:  Lesley J Scott; Katherine A Lyseng-Williamson; Karly P Garnock-Jones
Journal:  CNS Drugs       Date:  2012-10-01       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.